Capricor Therapeutics, Inc. (CAPR)

NASDAQ: CAPR · Real-Time Price · USD

9.59

-0.47 (-4.67%)

At close: Aug 28, 2026, 4:00 PM EDT

9.44

-0.15 (-1.56%)

Pre-market: Aug 31, 2026, 5:27 AM EDT

Capricor Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	20.94	287.85	11.29	14.69	9.6	34.89
Short-Term Investments	217	30.28	140.23	24.79	31.82	-
Cash & Short-Term Investments	237.93	318.13	151.52	39.49	41.42	34.89
Cash Growth	93.76%	109.96%	283.70%	-4.67%	18.74%	6.79%
Accounts Receivable	-	-	10	10.37	0.55	0.39
Other Receivables	-	0.06	0.37	-	-	-
Receivables	-	0.06	10.37	10.37	0.55	0.39
Prepaid Expenses	2.69	3.67	1.5	1	0.92	1.16
Other Current Assets	1.5	1.08	-	-	-	-
Total Current Assets	242.13	322.94	163.39	50.86	42.89	36.44
Property, Plant & Equipment	124.96	31.85	6.87	7.61	6.94	4.62
Other Long-Term Assets	1.65	1.16	0.22	0.27	0.27	0.28
Total Assets	368.74	355.95	170.48	58.73	50.09	41.33

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.08	1.65	3.28	6.24	4.83	3.12
Accrued Expenses	13.97	12.55	4.91	0.01	0.09	0.6
Current Portion of Leases	1.49	0.2	0.83	0.75	0.68	0.42
Current Unearned Revenue	12	12	12	24.27	17.98	-
Other Current Liabilities	2.42	9.43	-	-	-	-
Total Current Liabilities	32.96	35.84	21.03	31.27	23.59	4.13
Long-Term Leases	89.56	14.32	0.62	1.49	1.88	2.45
Long-Term Unearned Revenue	-	-	-	-	9.47	-
Other Long-Term Liabilities	-	-	3.38	3.38	3.38	3.38
Total Liabilities	122.52	50.16	25.02	36.13	38.31	9.96

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.06	0.06	0.05	0.03	0.03	0.02
Additional Paid-In Capital	625.88	610.33	344.22	181.7	148.74	139.4
Retained Earnings	-379.55	-304.88	-199.83	-159.37	-137.08	-108.06
Comprehensive Income & Other	-0.16	0.28	1.03	0.24	0.11	-
Shareholders' Equity	246.22	305.79	145.46	22.6	11.79	31.37
Total Liabilities & Equity	368.74	355.95	170.48	58.73	50.09	41.33

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	91.05	14.52	1.45	2.24	2.56	2.87
Net Cash (Debt)	146.89	303.61	150.06	37.25	38.86	32.01
Net Cash Growth	20.64%	102.32%	302.84%	-4.14%	21.38%	-1.03%
Net Cash Per Share	2.80	6.53	4.26	1.39	1.58	1.39
Filing Date Shares Outstanding	58.14	57.51	45.68	31.4	25.26	24.3
Total Common Shares Outstanding	58.11	57.37	45.58	31.15	25.24	24.19
Working Capital	209.17	287.1	142.36	19.59	19.3	32.3
Book Value Per Share	4.24	5.33	3.19	0.73	0.47	1.30
Tangible Book Value	246.22	305.79	145.46	22.6	11.79	31.37
Tangible Book Value Per Share	4.24	5.33	3.19	0.73	0.47	1.30
Machinery	18.4	9.24	6.51	5.64	4.38	0.04
Construction In Progress	20.38	11.44	-	-	-	-
Leasehold Improvements	3.71	2.79	2.5	2.13	1.39	2.51

SEC Filings: 10-K · 10-Q